Pieris Pharmaceuticals Inc banner

Wall St Price Targets

PVLA Price Forecast
Based on 18 analysts

+61% Upside
from $147.07 today

Pieris Pharmaceuticals Inc (PVLA)’s 12-month stock price forecast through November 2027 has a consensus target of $236.64, implying 61% upside. The forecast is based on price targets from 18 Wall Street analysts.

PVLA Analyst Rating
Based on 16 analysts

avg. 5 of 5
Strong buy
16 100%
Buy
0 0%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate PVLA Strong buy, with 16 of 16 recommending Buy or Strong buy.

Pieris Pharmaceuticals Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PVLA's stock price target?
Price Target
236.64 USD

According to Wall Street analysts, the average 1-year price target for PVLA is 236.64 USD with a low forecast of 209.07 USD and a high forecast of 280.35 USD.

Back to Top